90. Retinitis pigmentosa Clinical trials / Disease details


Clinical trials : 130 Drugs : 180 - (DrugBank : 41) / Drug target genes : 49 - Drug target pathways : 109

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000007895
2001/07/0101/06/2012Effects of nilvadipine on the progression of visual field defects in patients with retinitis pigmentosaEffects of nilvadipine on the progression of visual field defects in patients with retinitis pigmentosa - Effects of nilvadipine on the progression of retinitis pigmentosa retinitis pigmentosaTreated group: oral administration of nilvadipine 4mg per day

Control group: herenien, tocoferol or no medication as patients' requests
Department of Ophthalmology, Hirosaki University Graduate School of MedicineNULLComplete: follow-up complete20years-old80years-oldMale and Female40Phase 2Japan